-
Notice of Hainan Provincial Administration for Market Regulation on 16 batches of unqualified food (Issue 36, 2022
Time of Update: 2023-02-02
Recently, the Hainan Provincial Administration for Market Supervision organized random inspection of edible agricultural products, edible oils and fats and their products, pastries, catering foods, soy products, dairy products, tea and related products, sugar, grain processing products, starch and starch products, health food 11 major categories of food, a total of 902 batches, including 886 batches of qualified samples and 16 batches of unqualified samples (see attachment for testing items).
-
Express infects nearly 400 million people every year! The disease is expected to usher in a new vaccine
Time of Update: 2023-01-05
▎WuXi AppTec content team editorRecently, Takeda announced that the US Food and Drug Administration (FDA) accepted the Biologics License Application (BLA) for its dengue virus vaccine TAK-003 and granted priority review status.
-
APL-1202 orally combined with tislelizumab neoadjuvant therapy for muscle-invasive bladder cancer (MIBC) completed the first subject enrollment in phase II clinical trial
Time of Update: 2022-12-30
(hereinafter referred to as the "Company") conducted the APL-1202 oral combination with tislelizumab neoadjuvant therapy for muscle-invasive bladder cancer (MIBC), and recently completed the enrollment of the first subject in the phase II clinical trial.
-
Energy imports fell in the first 11 months
Time of Update: 2022-12-29
According to customs statistics, in the first 11 months of this year, China's crude oil, coal, natural gas and other imports fell in price.
According to customs statistics, in the first 11 months of this year, China's crude oil, coal, natural gas and other imports fell in price.
-
Milestone! Remegen Biotech tatacept was approved to conduct a global multi-center phase III clinical trial of SLE in the European Union and China
Time of Update: 2022-10-26
In order to facilitate patients' self-administration, improve the convenience of clinical medication, and the compliance of patients, Remegen has developed the liquid preparation of tetacept - tetacept(study code: RC18-L, prefilled injection), and carried out the global multicenter clinical trial of this liquid dosage form for the treatment of systemic lupus erythematosus.
-
The drafting of the group standard of "Enzyme Products - Dietary Fiber Composite Enzyme" was launched
Time of Update: 2022-09-20
(Reporter Sun Yanming) Recently, the "Enzyme Products - Dietary Fiber Compound Enzyme" group standard launch meeting and the first drafting work conference sponsored by the Enzyme Branch of the China Biological Fermentation Industry Association was held in Beijing.
-
The 22nd National Baking Professional Skills Competition Guangzhou Division Trials Held
Time of Update: 2022-08-31
, Ltd. and combined with the senior worker standards of the Guangzhou Catering Industry Vocational Skills Competition to assess the projects of Chinese pastry chefs and Western pastry chefs .
-
Methods of primary culture of C57 mouse skin fibroblasts
Time of Update: 2022-08-30
The company provides a full range of cell lines, cell culture reagents with stable quality, mature and efficient technical services, and professional and thoughtful technical support .
-
Automotive lightweighting requires the application and development of plastic automotive interiors
Time of Update: 2022-08-18
The development direction of plastic car interiorThe development direction of plastic car interior Lightweight: In the lightweight design and production of automotive interiors, it can be achieved through product structure optimization, material optimization, and new process microcellular foaming (physical foaming/chemical foaming) .
-
The overall performance of the traditional Chinese medicine sector achieved high growth and ushered in greater investment opportunities
Time of Update: 2022-05-14
Among them, the overall performance of the traditional Chinese medicine sector has also achieved high growth, with 30 traditional Chinese medicine companies having a net profit of more than 100 million yuan .
-
Spain emphasizes the important role played by the new bread quality standards
Time of Update: 2021-03-18
html" class="zdbq" title="Food related food information" target="_blank">Food Partners Reuters the Spanish Ministry of Agriculture, Fisheries and Food March 2 announced that Spain held the line on the same dayfoodmate.
html" class="zdbq" title="Bread-related food information" target="_blank">Bread foodmate.
-
BASF in Nanjing Chemical Park has added a production capacity of 20,000 tons of polyacrylamide
Time of Update: 2020-11-14
(BASF's polyacrylamide production facility in Nanjing Chemical Industrial Park has been completed and put into operation) Polyacrylamide Overview: Polyacrylamide (PAM) is a line polymer, the products are mainly divided into dry powder and collome two forms .
-
Silicon dioxide coatings are used as stone protection materials
Time of Update: 2020-10-09
Chemists have studied the possibility of using a modified silicon dioxide coating of 3-amino triethyl silane as a stone protective material.
studied silicon dioxide coatings modified with 3-amino triethyl silane (ATS) to test their potential use as a stone protective material.
-
How to effectively remove indoor formaldehyde What formaldehyde is fast and effective
Time of Update: 2020-10-09
Today, the more effective dealdehyde removal is in the indoor use of formaldehyde air purifier, purification indoor formaldehyde, formaldehyde air purifier is to remove formaldehyde fast and effective scientific and technological products, can be timely and efficient removal of indoor formaldehyde pollution .
-
FDA: Rare disease treatments remain a top priority for the FDA during the COVID-19 pandemic
Time of Update: 2020-08-19
other disturbing findings, 29 percent of respondents said they lost their jobs temporarily or permanently because of the COVID-19 pandemic; FDA staff, every day, do their best to promote the expanded use of research drugs by supporting sponsors and research institutions in clinical trials, and to help sponsors and research institutions work to prevent the COVID-19 pandemic from hindering the development of rare disease sedothing drugs and ensuring the continued availability of approved products critical to rare disease patients.
